Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 8,
Issue 17,
September 10 2024
View This Issue

Latest Articles

Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B
LMWH prevents thromboinflammation in the placenta via HBEGF-AKT signaling
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party study
A phase 2 study of a longitudinal multidimensional rehabilitation program for allogeneic blood and marrow transplantation patients
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
A boost for poor graft function
Myo1c drives actin-dependent VWF expulsion from EC WPBs
Prophylactic VSTs: a promising start but still work to do
Joseph JM, Hillengass J, Tang L, et al. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. Blood Adv. 2024;8(3):538-548.
The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas

Advertisement intended for health care professionals

ASH Statement in Support of the Value of Scholarly Publishers
Acknowledgement of Reviewers
ASH Commitment to Diversity, Equity, and Inclusion in Health Care

Featured Content

The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis

Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival

Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib

Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals